Cellectar Biosciences INC NEW (CLRB)

NASDAQ

$1,37

$-0,04

(-2,80%)

After-Hours

Cellectar Biosciences INC NEW (CLRB) Live Price Chart

Last updated: ⁦2026-10-13 20:07:40⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Cellectar Biosciences INC NEW (CLRB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,37, with a market capitalisation of $13,71M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,34 to $5,07. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$13,71M
Open	$1,55
Day's High	$116.670,00
Day's Low	$1,34
Previous Close	$1,43
Volume	491,49K
Average Volume	65,56K
P/E Ratio	--
52-Week High	$5,07
52-Week Low	$1,34
Dividend Yield	--
Earnings Date	--

Cellectar Biosciences INC NEW (CLRB) After-Hours Stock Price

Cellectar Biosciences INC NEW (CLRB) is trading at $1,39 in after-hours trading as of 2026-10-13 20:07:00, down 2,80% ($0,04) from the regular-session close of $1,43.

After-hours trading shows how investors are pricing CLRB after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Cellectar Biosciences INC NEW (CLRB) 7-Day Stock Price Change

Over the past seven days, Cellectar Biosciences INC NEW (CLRB) moved from $1,78 to $1,37, representing a decline of 22,81% ($0,41).

The stock traded between $1,34 and $1,98 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 116,86 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

CLRB 52-Week Price Position

Position in Range: 0,9%

52W Low$1,34

52W High$5,07

CLRB is currently trading at $1,37, placing it 0,9% of the way from its 52-week low of $1,34 to its 52-week high of $5,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cellectar Biosciences INC NEW (CLRB)?

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Cellectar Biosciences INC NEW Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	11
Exchange	NASDAQ
Company Website	https://www.cellectar.com

How to Buy Cellectar Biosciences INC NEW (CLRB) Stock on MEXC

Eligible investors can buy real shares of Cellectar Biosciences INC NEW (CLRB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CLRB and Place Your Order

Open the RealStocks trading page and search for CLRB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cellectar Biosciences INC NEW (CLRB) stock price today?

Cellectar Biosciences INC NEW (CLRB) is currently trading at $ 1,37, down 3,92% ($0,06) from the previous close of $ 1,43. Intraday prices update in real time during regular trading hours.

2.Is CLRB stock going up or down today?

As of 2026-10-13 20:07:00, CLRB is trading at $ 1,37, down 3,92% ($0,06) from its previous close of $ 1,43. The stock has traded between $ 1,34 and $ 116.670,00 during today’s regular session. Past price movements do not guarantee future results.

3.What is CLRB pre-market price?

As of 2026-10-13 20:07:00, CLRB is trading at $ 1,53 in pre-market trading, up 6,99% ($0,10) from the previous close of $ 1,43. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CLRB after-hours price?

As of 2026-10-13 20:07:00, CLRB is trading at $ 1,39 in after-hours trading, down 2,80% ($0,04) from the regular-session close of $ 1,43. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CLRB stock trading now?

CLRB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CLRB sit relative to its 52-week high and low?

Over the past 52 weeks, CLRB has traded between a low of $ 1,34 and a high of $ 5,07. At $ 1,37, the stock is positioned 0,9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cellectar Biosciences INC NEW in?

Cellectar Biosciences INC NEW (CLRB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cellectar Biosciences INC NEW's market capitalisation and where is it listed?

Cellectar Biosciences INC NEW is listed on the NASDAQ exchange with a market capitalisation of $ 13,71M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CLRB valued in terms of P/E ratio and EPS?

CLRB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2,36. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cellectar Biosciences INC NEW pay a dividend?

Cellectar Biosciences INC NEW pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.